JP2013521316A5 - - Google Patents

Download PDF

Info

Publication number
JP2013521316A5
JP2013521316A5 JP2012556409A JP2012556409A JP2013521316A5 JP 2013521316 A5 JP2013521316 A5 JP 2013521316A5 JP 2012556409 A JP2012556409 A JP 2012556409A JP 2012556409 A JP2012556409 A JP 2012556409A JP 2013521316 A5 JP2013521316 A5 JP 2013521316A5
Authority
JP
Japan
Prior art keywords
alkoxycarbonyl
acyl
optionally
group
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012556409A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013521316A (ja
JP5919202B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/001077 external-priority patent/WO2011110315A1/en
Publication of JP2013521316A publication Critical patent/JP2013521316A/ja
Publication of JP2013521316A5 publication Critical patent/JP2013521316A5/ja
Application granted granted Critical
Publication of JP5919202B2 publication Critical patent/JP5919202B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012556409A 2010-03-08 2011-03-04 医療用一酸化炭素放出レニウム化合物 Active JP5919202B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10002342.3 2010-03-08
EP10002342 2010-03-08
PCT/EP2011/001077 WO2011110315A1 (en) 2010-03-08 2011-03-04 Carbon monoxide releasing rhenium compounds for medical use

Publications (3)

Publication Number Publication Date
JP2013521316A JP2013521316A (ja) 2013-06-10
JP2013521316A5 true JP2013521316A5 (https=) 2014-04-24
JP5919202B2 JP5919202B2 (ja) 2016-05-18

Family

ID=43828395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012556409A Active JP5919202B2 (ja) 2010-03-08 2011-03-04 医療用一酸化炭素放出レニウム化合物

Country Status (6)

Country Link
US (2) US9512156B2 (https=)
EP (1) EP2545064B1 (https=)
JP (1) JP5919202B2 (https=)
CN (1) CN102791724A (https=)
CA (1) CA2792319A1 (https=)
WO (1) WO2011110315A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6134710B2 (ja) * 2011-07-21 2017-05-24 アルファーマ インコーポレイテッドAlfama,Inc. 一酸化ルテニウム放出分子およびその使用
EP2868348A1 (en) 2013-11-04 2015-05-06 Universität Zürich CO-releasing compounds & formulations thereof useful for inducing mitochondrial biogenesis and tissue repair

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
NZ534912A (en) * 2002-02-04 2007-08-31 Alfama Investigacao E Desenvol supramolecule aggregate comprising CO containing organometallic or transition metal complex and anti-inflammatory agent or biphosphonate phosphonate derivative
US20070207217A1 (en) 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
AU2004262976A1 (en) 2003-08-04 2005-02-17 Hemocorm Limited Use of boranocarbonates for the therapeutic delivery of carbon monoxide
KR20060095566A (ko) * 2003-10-20 2006-08-31 유니베르시태트 취리히 방사선치료적 화학독성 제제로서 금속 트리카르보닐복합체의 용도
ATE443070T1 (de) * 2004-01-08 2009-10-15 Univ Zuerich Metallkomplexe mit vitamin b12 als ligand
US20070207993A1 (en) 2005-12-20 2007-09-06 Alfama - Investigacao E Desenvolvimetno De Productos Farmaceuticos Lda Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
EP2182961B1 (en) 2007-07-24 2012-05-02 Alfama - Investigaçao e Desenvolvimento de Productos Farmaceuticos LDA. Prevention of gastric ulcery by carbon monoxide

Similar Documents

Publication Publication Date Title
JP6342805B2 (ja) 置換ピラゾロ[3,4−d]ピリミジンおよびその用途
US10343981B2 (en) Modulators of the eIF2alpha pathway
JP2018522866A5 (https=)
JP2019524883A5 (https=)
JP2016537366A5 (https=)
JP2019525962A (ja) ケモカイン受容体調節剤及びそれの使用
CA3080948A1 (en) Modulators of the integrated stress pathway
JP2013526544A5 (https=)
JP2018522867A5 (https=)
RU2016151420A (ru) Новое терапевтическое применение производных бензилиденгуанидина для лечения протеинопатий
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
JP2016513130A5 (https=)
JP2019535723A5 (https=)
JP2017538689A5 (https=)
JP2016513696A5 (https=)
JP2016531126A5 (https=)
MX2021006544A (es) Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer.
JP2016504400A5 (https=)
JP2017518360A5 (https=)
JP2016525104A5 (https=)
JP2015521195A5 (https=)
JP2019521964A5 (https=)
JP2025118609A (ja) Nurr1受容体調節因子
JP6422936B2 (ja) 5−ブロモ−インジルビン
JP2016537396A5 (https=)